ArticleJournal of neural transmission (Vienna, Austria : 1996)2026
Regional homogeneity differences in resting-state fMRI between Parkinson's disease and multiple system atrophy-parkinsonian type.
Article in Journal of neural transmission (Vienna, Austria : 1996), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Altered regional homogeneity in Parkinson's disease with mild cognitive impairment: a resting-state fMRI study.Frontiers in psychology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Both Parkinson's disease (PD) and the Multiple system atrophy-parkinsonian type (MSA-P) belong to the category of α-synucleinopathies, characterized by overlapping clinical manifestations and a high risk of misdiagnosis. The aim of this study is to provide objective imaging biomarkers for differentiating PD from MSA-P. We enrolled 25 patients with PD, 15 patients with MSA-P, and 20 healthy controls (HC). Resting-state functional magnetic resonance imaging (rs-fMRI) was employed to analyze regional homogeneity (ReHo) differences between PD and MSA-P groups. The discriminative capacity of ReHo values in these differential brain regions for distinguishing PD from MSA-P was subsequently evaluated. Compared to MSA-P, PD showed decreased ReHo in cerebellar lobule IX, left fusiform gyrus, and right thalamus, but increased ReHo in the right cuneus. In PD, ReHo in cerebellar lobule IX, left fusiform gyrus negatively correlated with UPDRS-III scores (r=- 0.8548, P< 0.001), while right cuneus ReHo positively correlated (r=0.6526, P=0.0004). The ReHo values in cerebellar lobule IX, left fusiform gyrus showed optimal discriminative power between PD and MSA-P groups, achieving an area under the curve (AUC) of 0.8693 (P< 0.001). Our study enhances understanding of altered neural synchronization in specific brain regions under rs-fMRI in PD and MSA-P. We established the link between ReHo changes in localized areas and PD clinical manifestations. Notably, ReHo alterations in cerebellar lobules IX and fusiform gyrus serve as potential biomarkers for differentiating PD from MSA-P.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.